AU2002357911A1 - APOMORPHINE INHIBITORS OF AMYLOID-Beta (ABeta) FIBRIL FORMATION AND THEIR USE IN AMYLOIDOSIS BASED DISEASE - Google Patents

APOMORPHINE INHIBITORS OF AMYLOID-Beta (ABeta) FIBRIL FORMATION AND THEIR USE IN AMYLOIDOSIS BASED DISEASE

Info

Publication number
AU2002357911A1
AU2002357911A1 AU2002357911A AU2002357911A AU2002357911A1 AU 2002357911 A1 AU2002357911 A1 AU 2002357911A1 AU 2002357911 A AU2002357911 A AU 2002357911A AU 2002357911 A AU2002357911 A AU 2002357911A AU 2002357911 A1 AU2002357911 A1 AU 2002357911A1
Authority
AU
Australia
Prior art keywords
abeta
apomorphine
amyloid
inhibitors
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002357911A
Other versions
AU2002357911A8 (en
Inventor
David J. E. Callaway
Hilal A. Lashuel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytokine Pharmasciences Inc
Original Assignee
Picower Institute for Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Picower Institute for Medical Research filed Critical Picower Institute for Medical Research
Publication of AU2002357911A8 publication Critical patent/AU2002357911A8/en
Publication of AU2002357911A1 publication Critical patent/AU2002357911A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
AU2002357911A 2001-12-20 2002-12-20 APOMORPHINE INHIBITORS OF AMYLOID-Beta (ABeta) FIBRIL FORMATION AND THEIR USE IN AMYLOIDOSIS BASED DISEASE Abandoned AU2002357911A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34122501P 2001-12-20 2001-12-20
US60/341,225 2001-12-20
PCT/US2002/040660 WO2003053356A2 (en) 2001-12-20 2002-12-20 APOMORPHINE INHIBITORS OF AMYLOID-β (Aβ) FIBRIL FORMATION AND THEIR USE IN AMYLOIDOSIS BASED DISEASE

Publications (2)

Publication Number Publication Date
AU2002357911A8 AU2002357911A8 (en) 2003-07-09
AU2002357911A1 true AU2002357911A1 (en) 2003-07-09

Family

ID=23336711

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002357911A Abandoned AU2002357911A1 (en) 2001-12-20 2002-12-20 APOMORPHINE INHIBITORS OF AMYLOID-Beta (ABeta) FIBRIL FORMATION AND THEIR USE IN AMYLOIDOSIS BASED DISEASE

Country Status (3)

Country Link
AU (1) AU2002357911A1 (en)
CA (1) CA2479263A1 (en)
WO (1) WO2003053356A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009149524A (en) * 2006-03-16 2009-07-09 Kyushu Univ Prophylactic and therapeutic agent for alzheimer's disease
GB0819530D0 (en) * 2008-10-24 2008-12-03 Univ Sheffield Methods and compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
US5744476A (en) * 1994-06-27 1998-04-28 Interneuron Pharmaceuticals, Inc. Dopamine D1 agonists for the treatment of dementia

Also Published As

Publication number Publication date
WO2003053356A2 (en) 2003-07-03
CA2479263A1 (en) 2003-07-03
WO2003053356A3 (en) 2003-09-12
AU2002357911A8 (en) 2003-07-09

Similar Documents

Publication Publication Date Title
AU2002324468A1 (en) Rapid improvement of cognition in conditions related to abeta
AU2003225668A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003213673A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003278135A1 (en) Liquid cleansing composition having simultaneous exfoliating and moisturizing properties
AUPR638101A0 (en) Composition and method for treatment of disease
AU2003303128A1 (en) Inhibitors and methods of use thereof
WO2005023143A8 (en) Illuminated electric toothbrushes and methods of use
AU2003207698A1 (en) Needle-suture combinations and methods of use
HUP0500042A3 (en) Use of hmg fragments as anti-inflammatory agents
AU2002306603A1 (en) In-situ gel formation of pectins
AU2003223579A1 (en) Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease
AU2003268531A1 (en) Materials and methods for treatment of allergic diseases
AU2003277215A1 (en) Novel neurokinin antagonists and methods of use thereof
AU2002350079A1 (en) Gel composition and methods of use
AU2002306624A1 (en) Heterocyclic analgesic compounds and methods of use thereof
AU2003210874A1 (en) Cleaning device and method of construction
AU2002309180A1 (en) Composition and kit for the treatment of inflammatory bowel diseases
AU2002357911A1 (en) APOMORPHINE INHIBITORS OF AMYLOID-Beta (ABeta) FIBRIL FORMATION AND THEIR USE IN AMYLOIDOSIS BASED DISEASE
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2003903597A0 (en) Treatment of premature ejaculation
AU2003251241A1 (en) Use of ceramics in pump liners
AU2001293557A1 (en) New inhibitors of iapp fibril formation and uses thereof
AU2003283938A1 (en) Use of certain compounds in treatment of obesity
AU2003215246A1 (en) Methods of reducing rhinovirus contagion and related compositions
AU2003256289A1 (en) Modified shine-dalgarno sequences and methods of use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase